Latest Blogs & Events

TherigySTM Hepatitis B (HBV) Outreach

We are excited to announce that we’ve added our 24th category to TherigySTM™: Hepatitis B (HBV), which became available on September 30.

The module, is a response to customer requests, and has some...

The Importance of Transparency and Proving Your Specialty Pharmacy’s Outcom...

As the healthcare industry continues to evolve, the name of the game is value. All stakeholders – as well as the public in general – are turning a discerning eye to the quality of care. This goes for...

Three Strategies to Differentiate Your Specialty Pharmacy from the Competit...

Specialty drugs have skyrocketed to one-third of the pharmacy industry’s revenue. This trend isn’t dying down: by 2020, it’s estimated to comprise half of the market. From small, independent...

Therigy Updates Brand: Emphasizes Future of Therapy Outcomes

Focuses on Building, Elevating, and Proving Specialty Pharmacy Value

Therigy®, the company that pioneered patient-focused specialty therapy management in 2006, is making a subtle, yet powerful...

Using Data to Improve Patient Safety

As a healthcare provider, you’ve made a commitment to ensure that every single patient receives the requisite level of care consistent with best practice guidelines while mitigating as many risks as...

U.S. House Passes Landmark Legislation for Medicare Home Infusion Reimburse...

In July, the U.S. House of Representatives made strides in improving Medicare programs by passing H.R. 3178, the Medicare Part B Improvement Act of 2017. This legislation consists of three titles...

A Call for Transparency: NASP Pushes Back on DIR Fees and PBM Collusion

This month, the National Association of Specialty Pharmacy (NASP) has made its position clear on two controversial issues involving specialty drug pricing. The organization argues that a lack of...

Specialty Pharmacy Beyond the U.S. Borders

Specialty pharmacy is exploding, and it’s not just in the States. While the U.S. is a global leader in specialty drug development and accessibility, market analysts are seeing unprecedented growth...

The Growth of Orphan Drugs

In 1983, the Orphan Drug Act was enacted to incentivize pharmaceutical manufacturers to research and develop treatments for rare diseases and conditions, which are generally defined as those that...

Limited Distribution Networks: Industry Impact and Tips for Securing LDD Co...

The explosion of specialty drugs into the pharmaceutical market has created a greater need for structure, accountability, and therapy success. As specialty drug manufacturers look to balance patient...

Using TherigySTM to Satisfy URAC Standards

Following the recent URAC Specialty Pharmacy v3.0 Accreditation webinar, we sent attendees a post-event survey. We gathered results. We took a close look. And, we are responding.

Many of you fine...

Specialty Pharmacy Consolidation: A Trend that Continues to Grow

With an estimated $115 billion in dispensed drugs and an impressive 28 percent share of the pharmaceuticals market in 2016, the specialty pharmacy industry continues to boom. This skyrocketing growth...

Specialty Pharmacy’s Strides in Managing Autoimmune Disorders and Rare Dise...

It’s estimated that from 2012 to 2016, orphan drug requests to the FDA doubled in volume. As of June 2017, there are more than 200 designation requests awaiting response. To remedy this, the FDA has...

Poll Results and Event Recap: URAC Specialty Pharmacy v3.0 Accreditation: L...

On Tuesday, July 11, over 350 professionals from specialty pharmacies and surrounding industries converged virtually for a webinar to help them better understand how to apply the changes that were...

DIR Fees: The Clawback Trend

Direct and indirect remuneration (DIR) fees are one of the most controversial topics in the pharmacy industry. Proponents of DIR fees state that they help to promote quality and value among pharmacy...

  Partner with Therigy to conduct outcomes studies based on real-world evidence across 20+ specialty disease states and 400+ specialty medications.
Learn More